Nigeria has taken delivery of the first medicine clinically proven to enhance Intelligent Quotient, IQ and memory with excitement.
Tyonex Ltd introduced the drug, Cognitol, into Nigeria and it has been warmly received by 300 physicians from various countries of West Africa that were present at the presentation.
Cognitol is a vinpocetine tablet derived from vincamine, an alkaloid of common periwinkle plant. It boosts the metabolism in the brain by increasing the blood flow, enhancing oxygen utilization accelerating the brain’s use of glucose. As a result, the brain can better retain information, thus enhancing memory.
This makes the medicine, arguably Nigeria’s first clinically proven IQ enhancer.
The drug, which comes in 5mg tablet formulation, has been in use in Nigeria for the past three years. Wednesday’s launching was just a formal introduction.
Tyonex Managing Director, Pharmacist Emmanuel Agba, said “Cognitol is a child of necessity. The content of the mind of any generation is decided by what it can remember. The success of any generation is determined by what it can bring out. Cognitol is a product that has come to ventilate that atmosphere, adding value to life and contributing to the cognitive development of Nigerians.”
He said the drug can correct a range of cerebral disorders such as poor memory, acute stroke, urinary incontinence, motor disorders and dizziness, tinnitus and other inner-ear problems and flagging libido.
Agba also said that it is important for brains to function optimally to be able to meet up with the dynamic pace at which the world is advancing.
“Today the world runs on a click of the mouse. Cognitol is like a catalyst that helps the mind to function properly. And at this point in our nation’s life, we need to function properly so that we can move top the next level,” he said.
“We have studied our society and realized that people have to deliver what they know, not what they don’t know. But what they know they need to deliver it at the right time. That is what Cognitol does, ” he added.
He said almost everyone above the age of 16 needs Cognitol. “From students desirous of making good grades to professionals such as doctors, bankers, pharmacists, nurses, architects, musicians, engineers, scientists and traders. “They all need Cognitol to rekindle the fire in them,” he added.
Dr. George Eze, Deputy Managing Director, Federal Neuropsychiatric Hospital, Benin said, “In the past, we have always known about Cognitol. We have always had this dilemma of dealing with our ageing geriatrics. As our hospital is developing, we found that most our patients’ problem is memory problem. Of course, we have dementias, old age and the gamut of amnesic problems. We are really trying Cognitol.”